FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices

New FDA-ABIA partnership enhances agency expertise in biomaterials, hybrids, composites and polymers Collaboration is first in polymer capacity for FDA WASHINGTON, D.C., Dec. 15, 2011 – Austen BioInnovation Institute in Akron (ABIA) […]

Dr. Frank Douglas Part of TEDMED Panel Exploring Cancer-Free World

On Tuesday, April 16, Dr. Frank L. Douglas, Austen BioInnovation Institute President and CEO, will participate in the TEDMED Conference during a special discussion on “The Value of Medical Innovation: […]

Austen BioInnovation Institute in Akron Begins Work on Roadmap for First U.S. Accountable Care Community

AKRON, Ohio – With the intent to create a healthier community and lessen the burden of disease in Akron, the Austen BioInnovation Institute in Akron (ABIA) has launched its Accountable […]